Agate Medical Investments

PeopleBio, Inc., a biotech company, engages in developing diagnostics for protein misfolding diseases worldwide. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. The company has strategic collaborations with Seoul National University Bundang Hospital, Etablissement Français du Sang, ADNI Private Partner Scientific Board, Eisai Co., Ltd., Macrogen Corp., ZheJiang Dian Diagnostics Co., Ltd., and LabGenomics, Inc. PeopleBio, Inc. was founded in 2002 and is based in Seongnam, South Korea.

Ornim, Inc. develops medical monitoring tools for the measurement of blood flow and oxygen saturation in patients. The company offers CerOx, a non-invasive monitor, which provides real-time data on oximetry and blood flow measurements of specific tissue. Its products are used for applications in neurological treatments and cardiac surgery. The company was founded in 2004 and is based in Santa Clarita, California. It has a research and development subsidiary operation in Israel.

U2Bio CO. LTD. provides medical IT solutions in South Korea. The company also offers clinical pathology, anatomical pathology, molecular diagnostics, and various diagnostic tests, and others. The company was founded in 2009 and is headquartered in Seoul, South Korea.

DarioHealth Corp is a digital health company. It is engaged in the development and commercialization of patented and proprietary technology that provides consumers with laboratory-testing capabilities using smartphones and other mobile devices. The company's product, Dario Blood sugar monitor is a mobile, real-time, cloud-based, diabetes management solution based on a multi-featured software application combined with a blood glucose monitoring device. The group operates internationally and derives revenues from the sale of its Dario smart meter and related device-specific disposables test strip cartridges and lancets. The company generates the majority of the revenue.

CLEW Medical Ltd. develops and delivers an analytics platform for healthcare providers and administrators to predict life threatening complications. Its platform harnesses the available ICU data to deliver predictive clinical analytics that provide hospital management and medical personnel with the preemptive information they require to manage the ICU floor, as well as alerts ICU teams about a patient's deterioration enabling early intervention and improving clinical outcomes. The company was founded in 2014 and is based in Netanya, Israel.

MST Medical Surgery Technologies Ltd. develops image analysis software for healthcare industry. It develops an image analysis software AutoLap, that facilitates robotic surgery, provides control of surgical procedure and an optimal field of view to surgeons; and Surgical Training Analytics (STA), a tool to captures images from actual surgical procedures performed by the surgeon in training. The company was founded in 2005 and is based in Tel Aviv, Israel with additional office in Apollo Beach, Florida.

OrNim Medical Ltd. operates as a bio-medical technology company that specializes in the clinical research, development, and distribution of monitoring devices for cerebral and tissue blood flow. The company’s portfolio includes c-FLOW system for use in neuro intensive care units, intensive care units, and operating rooms, as well as by specialist clinicians, intensivists, anesthesiologists, and/or other medical professionals for the non-invasive monitoring of microcirculation blood flow in adult tissue. Its c-FLOW system comprises c-FLOW monitor and ultrasound/UTLight sensors used with disposable smart pads. It distributes its products through authorized representatives in Europe. The company was founded in 2004 and is based in Kfar Saba, Israel. OrNim Medical Ltd. operates as a subsidiary of Ornim, Inc.

ForSight VISION6, Inc. develops ophthalmic products for visually impaired patients. It offers products for the treatment of glaucoma for adult irreversible blindness. The company was founded in 2014 and is based in Menlo Park, California. ForSight VISION6, Inc. operates as a subsidiary of ForSight Labs, LLC.

CLEW Medical Ltd. develops and delivers an analytics platform for healthcare providers and administrators to predict life threatening complications. Its platform harnesses the available ICU data to deliver predictive clinical analytics that provide hospital management and medical personnel with the preemptive information they require to manage the ICU floor, as well as alerts ICU teams about a patient's deterioration enabling early intervention and improving clinical outcomes. The company was founded in 2014 and is based in Netanya, Israel.

Navotek Medical Ltd. develops RealTrack intra-body tracking technology. Its products include RealEye, a fiducial-based patient positioning and real-time target monitoring system for radiation therapy; Tracer, an implantable fiducial that is designed for marking target tissue and enabling localization based on its radioactive signal; and RealEye Motion, an advanced software application add-on to the RealEye system that is designed to enable the monitoring and tracking of moving organs' paths throughout radiation therapy. The company was founded in 2005 and is based in Yokneam, Israel.

MST Medical Surgery Technologies Ltd. develops image analysis software for healthcare industry. It develops an image analysis software AutoLap, that facilitates robotic surgery, provides control of surgical procedure and an optimal field of view to surgeons; and Surgical Training Analytics (STA), a tool to captures images from actual surgical procedures performed by the surgeon in training. The company was founded in 2005 and is based in Tel Aviv, Israel with additional office in Apollo Beach, Florida.

MST Medical Surgery Technologies Ltd. develops image analysis software for healthcare industry. It develops an image analysis software AutoLap, that facilitates robotic surgery, provides control of surgical procedure and an optimal field of view to surgeons; and Surgical Training Analytics (STA), a tool to captures images from actual surgical procedures performed by the surgeon in training. The company was founded in 2005 and is based in Tel Aviv, Israel with additional office in Apollo Beach, Florida.

VisionCare Ophthalmic Technologies, Inc. operates as a specialty medical device company that engages in the research, development, manufacture, and marketing of implantable ophthalmic devices, and technologies that are intended to improve vision for individuals with untreatable retinal disorders. The company offers Implantable Miniature Telescope (IMT), an implantable medical device to improve vision and quality of life in individuals with end-stage age-related macular degeneration (AMD). Its telescope implant is integral to the CentraSight treatment program, which has been developed to help patients follow the necessary steps for proper diagnosis, surgical evaluation, and postoperative care. VisionCare Ophthalmic Technologies, Inc. was founded in 1997 and is based in Saratoga, California.

Ornim, Inc. develops medical monitoring tools for the measurement of blood flow and oxygen saturation in patients. The company offers CerOx, a non-invasive monitor, which provides real-time data on oximetry and blood flow measurements of specific tissue. Its products are used for applications in neurological treatments and cardiac surgery. The company was founded in 2004 and is based in Santa Clarita, California. It has a research and development subsidiary operation in Israel.

BrainsGate, Ltd., a medical device company, develops therapies for patients suffering from central nervous system (CNS) diseases. It offers a technology platform that involves electrical stimulation of the spheno-palatine ganglion (SPG), a nervous center known to increase cerebral blood flow. The company develops an ischemic stroke system that is based on an implantable electrode and is designed to deliver electrical stimulation to the spheno-palatine ganglion (SPG). Its system augments cerebral blood flow by using an external system temporarily attached to the patient’s cheek. BrainsGate, Ltd. was founded in 2000 and is based in Caesarea, Israel.

On June 30, 2020, Valeritas Holdings, Inc. went out of business as per its Chapter 11 liquidation filing under bankruptcy. Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States. The company offers V-Go, a wearable insulin delivery device for basal-bolus therapy. It also develops V-Go Prefill that is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go SIM for real-time tracking information of basal and bolus dosing utilization. The company sells V-Go to third-party wholesalers and medical supply distributors. Valeritas Holdings, Inc. was founded in 2006 and is headquartered in Bridgewater, New Jersey.

DiA Imaging Analysis provides advanced AI-based ultrasound analysis smarter and accessible. It solves the two main challenges clinicians face when using ultrasound: acquiring the right image and automatically analyzing it, to find clinical abnormalities that today they are struggling to find visually. DiA's automated tools can be easily be added into any ultrasound device or healthcare IT system, just like an App. The company holds FDA/CE Clearances for its cardiac toolbox, generating revenues and having thousands of users around the world.

Angioslide, founded in 2005 by Eran Hirszowicz and Amos Nahir, is a privately-held medical device company. The company has developed a unique Embolic Capture Angioplasty™ (ECA) device family that combines standard balloon angioplasty with debris removal capabilities through its suction mechanism. Physicians using the PROTEUS™ device can now capture and remove embolic particles during angioplasty procedures.

CLEW Medical Ltd. develops and delivers an analytics platform for healthcare providers and administrators to predict life threatening complications. Its platform harnesses the available ICU data to deliver predictive clinical analytics that provide hospital management and medical personnel with the preemptive information they require to manage the ICU floor, as well as alerts ICU teams about a patient's deterioration enabling early intervention and improving clinical outcomes. The company was founded in 2014 and is based in Netanya, Israel.

Sensimed designs, develops, and commercializes integrated micro-systems for medical devices. The company’s product portfolio includes SENSIMED Triggerfish, a product that offers an automated recoding of continuous ocular dimensional change over 24 hours. Sensimed is now focused on expanding the knowledge of how this individual data can best be used in the clinical setting to deliver customized treatment. The 24 hour profiles are being centralized on a registry together with patient and treatment information. The data is being analyzed and modeled on an ongoing basis in an attempt to identifying pathological patterns that can be used to differentiate indication, personalize treatment and assess efficacy following treatment. Sensimed was founded by Matteo Leonardi and Sacha Cerboni in August 2003 and is based in Lausanne, Switzerland.

Angioslide, founded in 2005 by Eran Hirszowicz and Amos Nahir, is a privately-held medical device company. The company has developed a unique Embolic Capture Angioplasty™ (ECA) device family that combines standard balloon angioplasty with debris removal capabilities through its suction mechanism. Physicians using the PROTEUS™ device can now capture and remove embolic particles during angioplasty procedures.

BrainsGate, Ltd., a medical device company, develops therapies for patients suffering from central nervous system (CNS) diseases. It offers a technology platform that involves electrical stimulation of the spheno-palatine ganglion (SPG), a nervous center known to increase cerebral blood flow. The company develops an ischemic stroke system that is based on an implantable electrode and is designed to deliver electrical stimulation to the spheno-palatine ganglion (SPG). Its system augments cerebral blood flow by using an external system temporarily attached to the patient’s cheek. BrainsGate, Ltd. was founded in 2000 and is based in Caesarea, Israel.

Peptron is a biotech company developing a wide range of peptide and small molecule based drugs to treat chronic and life-threatening disorders. Its initial focus is to provide long-term cure for neurodegenerative, cancer and endocrine related diseases. Peptron integrates the extensive experience of peptide research, drug development and expertise in drug delivery technologies for more than 15 years combined with a patients-focused approach driven by excellence.

The Lumenis surgical laser division is a global leader in advanced medical laser equipment and surgical laser technology. Lumenis is a pioneer in the field of laser for surgery and its cutting-edge devices are being used by top medical professionals and facilities around the world. The company Provides Urology laser, Gynecology laser, ENT laser and more systems for medical applications.

ECPM is a medical device company focused on designing and commercializing a platform of products and services for gastrointestinal caregivers. The Company offers a range of products and services that span single-use devices and infection control products, pathology, and imaging systems. Its products are used in colonoscopy and procedures of the upper GI tract, including esophagogastroduodenoscopy (EGD). The company is headquartered in Alpharetta, Georgia.

Angioslide, founded in 2005 by Eran Hirszowicz and Amos Nahir, is a privately-held medical device company. The company has developed a unique Embolic Capture Angioplasty™ (ECA) device family that combines standard balloon angioplasty with debris removal capabilities through its suction mechanism. Physicians using the PROTEUS™ device can now capture and remove embolic particles during angioplasty procedures.

their mission is to develop safe and effective neurovascular medical devices that are beneficial to patients and meet physicians' needs. They are committed to advancing patient care by providing the most reliable, easiest to use and highest quality products supported by proven clinical data. Rapid Medical is located at the northern part of Israel between the Carmel Mountain and the hills of Ramot Menashe.

BrainsGate, Ltd., a medical device company, develops therapies for patients suffering from central nervous system (CNS) diseases. It offers a technology platform that involves electrical stimulation of the spheno-palatine ganglion (SPG), a nervous center known to increase cerebral blood flow. The company develops an ischemic stroke system that is based on an implantable electrode and is designed to deliver electrical stimulation to the spheno-palatine ganglion (SPG). Its system augments cerebral blood flow by using an external system temporarily attached to the patient’s cheek. BrainsGate, Ltd. was founded in 2000 and is based in Caesarea, Israel.

BIOINFRA Life Science Inc., a healthcare company, develops cancer gene treatments and technologies that monitor the possibility of metastasis and recurrence in blood for cancer patients in South Korea. Its portfolio includes cancer screening test technology, cancer biomarker research, in-vitro diagnostics medical devices, and targeted drug delivery systems for cancer treatment. The company was founded in 2001 and is based in Seoul, South Korea.

BrainsGate, Ltd., a medical device company, develops therapies for patients suffering from central nervous system (CNS) diseases. It offers a technology platform that involves electrical stimulation of the spheno-palatine ganglion (SPG), a nervous center known to increase cerebral blood flow. The company develops an ischemic stroke system that is based on an implantable electrode and is designed to deliver electrical stimulation to the spheno-palatine ganglion (SPG). Its system augments cerebral blood flow by using an external system temporarily attached to the patient’s cheek. BrainsGate, Ltd. was founded in 2000 and is based in Caesarea, Israel.

Navotek Medical develops real-time innovative tracking and navigation solutions for medical applications. The first application is in the oncology field, providing tumor localization and tracking for optimal radiation therapy. Navotek’s solution will allow for safer and more effective treatment, improving the chances of tumor eradication and decreasing the rate of complications. In addition, it will potentially improve the efficiency of the treatment procedure by shortening individual sessions as well as entire treatment courses. This will increase the radiation rooms’ throughput which will translate into increased earnings for the hospital.

HEALCERION (힐세리온) is a Korean incubator that offers a mobile-based healthcare system for providing physicians and patients with ultra-portability. It provides timely diagnostic testing results and actionable healthcare information to help ensure proper patient care and client satisfaction. HEALCERION is also the developer of the world’s first wireless ultrasound system which can be easily operated with one hand, transmitting ultrasound images via a wireless access point to any mobile-based tablet and mobile phone screen.

Mitos Medical Ltd develops and supplies laparoscopy and endoscopy visual optical devices for physicians and their patients. The company was founded in 2016 and is based in Netanya, Israel.

Angioslide, founded in 2005 by Eran Hirszowicz and Amos Nahir, is a privately-held medical device company. The company has developed a unique Embolic Capture Angioplasty™ (ECA) device family that combines standard balloon angioplasty with debris removal capabilities through its suction mechanism. Physicians using the PROTEUS™ device can now capture and remove embolic particles during angioplasty procedures.

Curaco, Inc. develops a nursing bidet/automatic toileting aid system for bedridden persons. The company’s system detects urine and/or feces with its built-in sensors, as well as automatically flushes excrement away, and rinses and dries the user’s body. It offers its system to seniors (elderly), patients, disabled and ill persons, hospitals, hospices, welfare facilities, senior-care facilities, and nursing homes. The company was founded in 2007 and is based in Seongnam, South Korea.

Tulip Medical Ltd., a medical device company, develops a solution for the overweight and obesity epidemic markets. Its TrimWeight, an oral, self- administered, and biodegradable device that induces a lasting sense of satiety. The company focuses on the self-pay and medically-insured overweight and mild obese market. It develops a disposable medical device that is swallowed as a regular capsule. The company was incorporated in 2005 and is based in Herzliya, Israel.

CLEW Medical Ltd. develops and delivers an analytics platform for healthcare providers and administrators to predict life threatening complications. Its platform harnesses the available ICU data to deliver predictive clinical analytics that provide hospital management and medical personnel with the preemptive information they require to manage the ICU floor, as well as alerts ICU teams about a patient's deterioration enabling early intervention and improving clinical outcomes. The company was founded in 2014 and is based in Netanya, Israel.

Sensimed designs, develops, and commercializes integrated micro-systems for medical devices. The company’s product portfolio includes SENSIMED Triggerfish, a product that offers an automated recoding of continuous ocular dimensional change over 24 hours. Sensimed is now focused on expanding the knowledge of how this individual data can best be used in the clinical setting to deliver customized treatment. The 24 hour profiles are being centralized on a registry together with patient and treatment information. The data is being analyzed and modeled on an ongoing basis in an attempt to identifying pathological patterns that can be used to differentiate indication, personalize treatment and assess efficacy following treatment. Sensimed was founded by Matteo Leonardi and Sacha Cerboni in August 2003 and is based in Lausanne, Switzerland.

Iscare specializes in assisted reproduction, complex treatment of obesity, gastroenterology, and treatment of idiopathic intestinal inflammations